Math below assumes a 1 mg vial reconstituted with 2 mL of BAC water at a typical 40 mcg/day dose (25 days per vial)
Rather than targeting a single receptor pathway, this advanced 10,000mcg blend unifies two distinct synthetic peptide architectures: a growth hormone-releasing hormone (GHRH) receptor agonist and a highly potent growth hormone secretagogue receptor (GHS-R1a) agonist
Selectivity Advantage: Unlike GHRP-2 and GHRP-6, which non-selectively activate multiple pituitary hormone pathways (ACTH, cortisol, prolactin), ipamorelin demonstrates minimal cross-reactivity with non-target pituitary receptors, making it pharmacologically similar to GHRH in its hormone-releasing selectivity
Peak GH secretion usually occurs 30-60 minutes post injection [7, 8]
It can provide the exact components at the cellular level necessary for aged, injured or diseased tissues and organs to heal and regenerate, thus providing incredible anti-aging, health & beauty benefits at the same time
